PAVmed Inc.
PAVM
$9.11
-$0.22-2.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 52.00K | 5.00K | 6.00K | 8.00K | 10.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 52.00K | 5.00K | 6.00K | 8.00K | 10.00K |
| Cost of Revenue | 85.00K | 55.00K | 41.00K | 36.00K | 48.00K |
| Gross Profit | -33.00K | -50.00K | -35.00K | -28.00K | -38.00K |
| SG&A Expenses | 4.94M | 3.71M | 3.89M | 4.63M | 4.34M |
| Depreciation & Amortization | -- | -- | -- | -- | 0.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.86M | 4.85M | 4.72M | 5.45M | 5.20M |
| Operating Income | -6.80M | -4.84M | -4.72M | -5.45M | -5.19M |
| Income Before Tax | -2.76M | -6.01M | -12.32M | 18.62M | 1.14M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.76M | -6.01M | -12.32M | 18.62M | 1.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.49M | 628.00K | 403.00K | 345.00K | 289.00K |
| Net Income | -1.26M | -5.38M | -11.92M | 18.97M | 1.43M |
| EBIT | -6.80M | -4.84M | -4.72M | -5.45M | -5.19M |
| EBITDA | -6.79M | -4.82M | -4.69M | -5.40M | -5.12M |
| EPS Basic | 0.45 | -8.81 | -22.08 | 38.26 | 3.73 |
| Normalized Basic EPS | 0.05 | -0.46 | -0.87 | -2.33 | -2.55 |
| EPS Diluted | -4.07 | -8.81 | -22.20 | 10.20 | -0.36 |
| Normalized Diluted EPS | 0.05 | -0.46 | -0.87 | -0.62 | -0.21 |
| Average Basic Shares Outstanding | 895.20K | 718.50K | 602.80K | 462.50K | 360.90K |
| Average Diluted Shares Outstanding | 895.20K | 718.50K | 602.80K | 1.75M | 4.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |